Exact Sciences' shares pop on positive Cologuard trial results

Kevin Conroy, Exact Sciences CEO, joins 'Fast Money' to discuss Exact Sciences latest trial results for its colo-rectal cancer tests, Cologuard.

Пікірлер: 10

  • @landonp629
    @landonp629 Жыл бұрын

    Where these studies independent? I don't trust studies conducted by the company selling the product.

  • @brianwhite1189
    @brianwhite1189 Жыл бұрын

    I did it and it's so easy. My insurance will fully cover the cost every three years, so there's no excuse not to.

  • @888strummer
    @888strummer Жыл бұрын

    Much easier than scheduling with a doctor and doing the common procedure. 100% easier and more pleasant

  • @landonp629

    @landonp629

    Жыл бұрын

    Yes, but its pretty worthless to PREVENT colorectal cancer. A coloscopy allows the doctor to remove pre-cancerous lesions before they become cancer - Cologuard will tell you when you HAVE Cancer (at least 94% of the time).

  • @888strummer

    @888strummer

    Жыл бұрын

    @@landonp629 I thought it was the same as the doctor's procedure. Are you sure about this?

  • @CocoChanelle-1

    @CocoChanelle-1

    Жыл бұрын

    @@landonp629that’s true. My friend caught 2 polyps and had them removed.

  • @FireEverLiving
    @FireEverLiving Жыл бұрын

    I know it's a good and useful product, but a lot of this conversation sounds like something from Futurama. Whoever named it Cologuard instead of giving it a usual corporate drug name like "Vightify" had a sense of humor.

  • @user-ov6cj7ys4h
    @user-ov6cj7ys4h3 ай бұрын

    Chemical Bank